Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-005662

President, R&D acquired 64,950 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2022-01-27 Grant or award +64,950 109,920 D
Derivatives
Bergstrom Donald A President, R&D 2022-01-27 Grant or award · Stock Option (Right to Buy) +129,900 129,900 D
Loading xslF345X03/doc4.xml…